Royal Bank of Canada’s Sanara MedTech SMTI Stock Holding History

Royal Bank of Canada’s Portfolio SMTI Stock Details SMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.26M	Buy	131,389 +13,746	+12%	+$283K	﹤0.01%	3001
2025 Q4	$2.75M	Buy	117,643 +65,887	+127%	+$1.7M	﹤0.01%	2893
2025 Q3	$1.64M	Buy	51,756 +19,129	+59%	+$577K	﹤0.01%	3567
2025 Q2	$927K	Buy	32,627 +996	+3%	+$29.9K	﹤0.01%	3959
2025 Q1	$976K	Buy	31,631 +21	+0.1%	+$713	﹤0.01%	3504
2024 Q4	$1.05M	Buy	31,610 +5,176	+20%	+$176K	﹤0.01%	3504
2024 Q3	$800K	Buy	26,434 +10,964	+71%	+$342K	﹤0.01%	3721
2024 Q2	$437K	Buy	15,470 +5,649	+58%	+$177K	﹤0.01%	4126
2024 Q1	$363K	Buy	9,821 +8,314	+552%	+$311K	﹤0.01%	4188
2023 Q4	$62K	Buy	1,507 +976	+184%	+$31.3K	﹤0.01%	5892
2023 Q3	$17K	Buy	531 +46	+9%	+$1.78K	﹤0.01%	6241
2023 Q2	$20K	Buy	+485	New	+$19.8K	﹤0.01%	6221
2022 Q4	–	Sell	-14	Closed	–	–	7668
2022 Q3	$0	Buy	14 +13	+1,300%	+$364	﹤0.01%	7817
2022 Q2	$0	Hold	1	–	–	﹤0.01%	7686
2022 Q1	$0	Buy	+1	New	+$25	﹤0.01%	7986
2021 Q4	–	Sell	-2,000	Closed	-$69K	–	7870
2021 Q3	$69K	Hold	2,000	–	–	﹤0.01%	5966
2021 Q2	$74K	Buy	+2,000	New	+$58.5K	﹤0.01%	5780

Other funds holding SMTI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SWM

Stonebridge Wealth Management Oak Brook, Illinois $112M AUM 23.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Royal Bank of Canada's SMTI Position: Q1 2026 in Review

Royal Bank of Canada increased its Sanara MedTech (SMTI) stake by 12% in Q1 2026, buying an estimated $283K and bringing the position to 131,389 shares worth $2.26M. The position accounts for ﹤0.01% of the portfolio, ranked #3001.

Royal Bank of Canada first reported a position in SMTI in Q2 2021 and has held it in 17 quarters since. The position peaked at $2.75M in Q4 2025. 65 funds tracked by Wall St. Rank hold SMTI as of Q1 2026.

Royal Bank of Canada held 131,389 shares of Sanara MedTech worth $2.26M as of Q1 2026.
Royal Bank of Canada bought 13,746 Sanara MedTech shares in Q1 2026, an estimated $283K.
Sanara MedTech made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #3001 holding.
Royal Bank of Canada first reported a position in Sanara MedTech in Q2 2021 and has held it in 17 quarters since.
Royal Bank of Canada's Sanara MedTech position peaked at $2.75M in Q4 2025.
65 funds tracked by Wall St. Rank held Sanara MedTech as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.